We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves New Orphan Drug for Chronic Myelogenous Leukemia

News   Sep 11, 2012

 
FDA Approves New Orphan Drug for Chronic Myelogenous Leukemia
 
 
 

RELATED ARTICLES

Cancer Study May Accidentally Help Researchers Create Usable Blood Stem Cells

News

A University of Colorado Cancer Center study identifies a potential new way to convince pluripotent cells to make hematopoietic stem cells. And, ironically, a possible way to do this lies in magnifying a gene that causes a form of childhood leukemia.

READ MORE

Could B Cells Be the New Allies in Sarcoma Immunotherapy?

News

New research published in Nature suggests that B cells also play a major role in predicting of patient’s response to immunotherapy, whilst it was previously thought only T cells could be used in this way.

READ MORE

Scientists Breach Brain Barriers To Tackle Tumors

News

Yale researchers have discovered a novel way to evade the brain’s natural defenses by slipping immune system “rescuers” through its drainage system.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE